Synthesis, in vitro and computational studies of novel glycosyl-1, 2, 3-1H-triazolyl methyl benzamide derivatives as potential α-glucosidase inhibitory activity
作者:Akhilesh Kumar Shukla、Manoj Kumar Shrivash、Anwesh Pandey、Jyoti Pandey
DOI:10.1016/j.bioorg.2021.104687
日期:2021.4
novel glycosyl-1,2,3-1H-triazolyl methyl benzamide analogues were synthesized by the unambiguous strategy and evaluated for α-glucosidase inhibitory activity. Glycosyl benzamide exhibited a dose-dependent inhibition of α-glucosidase activity. The In-vitro α-glucosidase inhibition activity results indicated that all the synthesized triazolyl methyl benzamide compounds (IC50 values ranging from 25.3 ± 0
通过明确的策略合成了一系列新型糖基-1,2,3-1 H-三唑基甲基苯甲酰胺类似物,并评估了α-葡萄糖苷酶抑制活性。糖基苯甲酰胺表现出对α-葡萄糖苷酶活性的剂量依赖性抑制。在体外α葡萄糖苷酶抑制活性的结果表明,所有合成的三唑基甲基苯甲酰胺化合物(IC 50个值范围为25.3±0.8至118.5±5.3μM)显示出在与标准药物阿卡波糖相比更多的抑制活性(IC 50 = 750.0 ± 12.5 微米)。其中,3 种脱乙酰糖基甲基苯甲酰胺衍生物(4c、4d和4f)显示出有希望的 α-葡萄糖苷酶抑制活性,IC 50值分别为25.3 ± 0.8、26.1 ± 1.5 和 30.6 ± 2.1。此外,这些化合物还进行了分子对接和分子动力学模拟研究。在(PDB ID:3A4A)靶蛋白和这些合成分子之间进行分子对接研究。这些化合物在 -7.5 至 -7.8 Kcal/mol 范围内显示出良好的对接能量。这项工作可用作识别具有